Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC
18h agoen
From the article
Conditions : MIBC Interventions : Drug: Gemcitabine; Drug: Toripalimab; Drug: Disitamab Vedotin (RC48); Procedure: Radical Cystectomy Sponsors : Zhiquan Hu; Tongji Hospital Recruiting
Continue reading on clinicaltrials.govYou might also wanna read
PICC-2: Toripalimab Plus Celecoxib Improves pCR in dMMR Locally Advanced Colorectal Cancer
OncoDaily·8h ago
Real-World EV Plus Pembro Success Seen in Urothelial Cancer
Medscape·1d ago
Antibody-Drug Conjugates in Perioperative Treatment of Muscle-Invasive Bladder Cancer: Expert Perspectives
This article discusses the emerging role of antibody-drug conjugates (ADCs) in the perioperative treatment of muscle-invasive bladder cancer
mdsc.pe·9d agoPolatuzumab Vedotin Boosts Survival in Relapsed DLBCL
Medscape·9h ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.